Cardlytics (Cardlytics) Change In Receivables : $-15.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cardlytics Change In Receivables?

Cardlytics's change in receivables for the quarter that ended in Mar. 2024 was $13.3 Mil. It means Cardlytics's Accounts Receivable declined by $13.3 Mil from Dec. 2023 to Mar. 2024 .

Cardlytics's change in receivables for the fiscal year that ended in Dec. 2023 was $-7.7 Mil. It means Cardlytics's Accounts Receivable increased by $7.7 Mil from Dec. 2022 to Dec. 2023 .

Cardlytics's Accounts Receivable for the quarter that ended in Mar. 2024 was $105.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cardlytics's Days Sales Outstanding for the three months ended in Mar. 2024 was 141.94.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cardlytics's liquidation value for the three months ended in Mar. 2024 was $-193.2 Mil.

Cardlytics Change In Receivables Historical Data

The historical data trend for Cardlytics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardlytics Change In Receivables Chart

Cardlytics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-26.02

-2.40

-27.94

-4.55

-7.73

Cardlytics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															21.41	-3.34	-7.08	-18.72	13.32

Cardlytics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.8 Mil.

Cardlytics (NAS:CDLX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cardlytics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	105.164	/	67.608	*	91
=	141.94

2. In Ben Graham's calculation of liquidation value, Cardlytics's accounts receivable are only considered to be worth 75% of book value:

Cardlytics's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	97.766	-	369.814	+	0.75 * 105.164	+	0.5 * 0
=	-193.2

Cardlytics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cardlytics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardlytics (Cardlytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Cardlytics Inc (NAS:CDLX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CYX:Germany

Address

675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, GA, USA, 30308

Website

https://www.cardlytics.com

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Executives

Clifford Sosin	10 percent owner	8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880
Karim Saad Temsamani	director, officer: Chief Executive Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Nicholas Hollmeyer Lynton	officer: Chief Legal & Privacy Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Alex Mishurov	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308
Scott A Hill	director	INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328
Alexis Desieno	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Andrew Christiansen	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Chris Suh	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308
Jessica Jensen	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Amit Gupta	officer: Chief Operating Officer	C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
John V Balen	director
Scott D. Grimes	director, officer: Chief Executive Officer	CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Lynne Marie Laube	director, officer: Chief Operating Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Kirk Somers	officer: Chief Legal & Privacy Officer
S Aimee Lapic	director	2101 WEBSTER ST #1650, OAKLAND CA 94612